Relief Therapeutics Holding AG (RLFTF)

[SF Wolf]

From my perspective trading volume is the key indicator at this juncture of what to expect while we wait for news on study outcomes, DMC report, FDA approval, etc. So far in September daily totals are in the plus/minus 10 million share range except September 4th when we traded 12 million and that was an up day. Trading volume is why down from last month when the stock had exponential price increases.

Massive amounts of stock are held by insiders and major investors who have a clear view of what is happening with the company and are not dependent on PRs and interviews, as we retail investors are.

Those insiders and investors are sitting on huge profits.

If internal company developments were going south, with negative outcomes, we would expect to see selling on a substantial scale driving down the stock price. That has not been the case. The stock has held steady, precisely because insiders are not selling.

Draw your own conclusions but I am confident we will be rewarded for our patience and Relief Therapeutics will be successful in bringing its drug to market.